BF-PARADAC- acetaminophen tablet
Bright Future Pharmaceutical Laboratories Limited
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
For temporary relief of minor aches and pains associated with the common cold, headache, toothache, muscular ache, to reduce fever
Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take:
• More than 6tablets in 24 hours, which is the maximum daily amount
• With other drugs containing acetaminophen
• 3 or more alcoholic drinks every day while using this product
Allergy alert: Acetaminophen may cayse severe skin reactions. Symptoms may include
• Skin reddening
• Blisters
• Rash
If skin reaction occurs, stop use and seek medical help right away
• With any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
• For more than 10 days for pain unless directed by a doctor
• For more than 3 days for fever unless directed by a doctor
• Symptoms do not improve
• New symptoms occur
• Pain or fever persists or gets worse
Do not take more than directed (see overdose warning)
Adults and children 12 years and over:
• Take 2 tablets every 6 hours while symptoms last
• Swallow whole – do not crush, chew or dissolve
• Do not take more than 6 tablets in 24 hours, unless directed by a doctor
• Do not use for more than 10 days unless directed by a doctor
Children under 12 years
• Ask a doctor
BF-PARADAC
acetaminophen tablet |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - Bright Future Pharmaceutical Laboratories Limited (663118677) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Bright Future Pharmaceutical Laboratories Limited | 663118677 | manufacture(10884-2228) |